EF
RMD icon

Empirical Finance’s ResMed RMD Stock Holding History

Empirical Finance’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1,000K Buy
5,130
+170
+3% +$35.2K 0.04% 309
2026
Q1 		$1.11M Sell
4,960
-8
-0.2% -$1.99K 0.05% 278
2025
Q4 		$1.2M Sell
4,968
-209
-4% -$53.4K 0.06% 259
2025
Q3 		$1.42M Buy
5,177
+50
+1% +$13.7K 0.07% 241
2025
Q2 		$1.32M Buy
5,127
+35
+0.7% +$8.35K 0.07% 245
2025
Q1 		$1.14M Buy
5,092
+131
+3% +$30.6K 0.07% 251
2024
Q4 		$1.13M Sell
4,961
-48
-1% -$11.6K 0.07% 244
2024
Q3 		$1.22M Buy
5,009
+99
+2% +$22.1K 0.07% 246
2024
Q2 		$940K Sell
4,910
-322
-6% -$65.3K 0.06% 277
2024
Q1 		$1.04M Buy
5,232
+179
+4% +$32.8K 0.06% 274
2023
Q4 		$869K Buy
5,053
+39
+0.8% +$5.99K 0.06% 284
2023
Q3 		$741K Buy
5,014
+494
+11% +$89.3K 0.05% 295
2023
Q2 		$988K Buy
4,520
+542
+14% +$121K 0.08% 239
2023
Q1 		$871K Buy
3,978
+202
+5% +$43.8K 0.08% 244
2022
Q4 		$786K Buy
3,776
+315
+9% +$69.2K 0.08% 249
2022
Q3 		$756K Buy
3,461
+584
+20% +$133K 0.09% 216
2022
Q2 		$603K Buy
2,877
+157
+6% +$33.4K 0.08% 239
2022
Q1 		$660K Buy
2,720
+307
+13% +$74.3K 0.07% 242
2021
Q4 		$629K Buy
2,413
+669
+38% +$174K 0.07% 243
2021
Q3 		$460K Buy
1,744
+114
+7% +$31.2K 0.07% 274
2021
Q2 		$402K Buy
1,630
+258
+19% +$54.2K 0.07% 281
2021
Q1 		$292K Hold
1,372
– – 0.05% 270
2020
Q4 		$292K Buy
+1,372
New +$274K 0.05% 270

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Empirical Finance's RMD Position: Q2 2026 in Review

Empirical Finance increased its ResMed (RMD) stake by 3.4% in Q2 2026, buying an estimated $35.2K and bringing the position to 5,130 shares worth $1,000K. The position accounts for 0.04% of the portfolio, ranked #309.

Empirical Finance first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.42M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Empirical Finance held 5,130 shares of ResMed worth $1,000K as of Q2 2026.
  • Empirical Finance bought 170 ResMed shares in Q2 2026, an estimated $35.2K.
  • ResMed made up 0.04% of Empirical Finance's portfolio in Q2 2026, its #309 holding.
  • Empirical Finance first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
  • Empirical Finance's ResMed position peaked at $1.42M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.